Rohypnol â contâd. Rohypnol Overview RohypnolÂ® is a trade name for flunitrazepam, a central nervous system (CNS) depressant that belongs to a class of drugs known as benzodiazepines. Flunitrazepam is also marketed as generic preparations and other trade name products outside of the United States.
(May 2013). An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.
conditions and side effects are common consequences of OT, and may occur during both short-term and long-term opioid therapy (LOT). Risk Mitigation The greatest risk factors for the development of opioid-related adverse events are the duration and dose of opioid analgesic use. 1 Many other factors also increase the risk of adverse outcomes